Status:
COMPLETED
Efficacy of Oral Ivabradine in Patients Presenting With NSTEMI
Lead Sponsor:
Cairo University
Collaborating Sponsors:
National Heart Institute, Egypt
Conditions:
NSTEMI
Eligibility:
All Genders
18-60 years
Phase:
PHASE2
PHASE3
Brief Summary
This study aims to evaluate the beneficial effect of heart rate reduction of oral ivabradine in patients presenting with non ST-segment elevation myocardial infarction (NSTEMI) during acute stage post...
Eligibility Criteria
Inclusion
- Patients with NSTEMI with normal sinus rhythm and heart rate (HR) more than 70 beats per minute (bpm) and systolic blood pressure (SBP) \>90 mm Hg undergoing PCI
Exclusion
- Patients needing urgent cardiac surgery, IV inotropic agents or had a HR less than 60 bpm without any medication.
Key Trial Info
Start Date :
December 1 2014
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 1 2016
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT04285736
Start Date
December 1 2014
End Date
May 1 2016
Last Update
August 22 2024
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.